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Reduced food intake, avoidingmalnutrition, can ameliorate aging and aging-associated diseases in
invertebrate model organisms, rodents, primates, and humans. Recent findings indicate that meal
timing is crucial, with both intermittent fasting and adjusted diurnal rhythm of feeding improving
health and function, in the absence of changes in overall intake. Lowered intake of particular nutri-
ents rather than of overall calories is also key, with protein and specific amino acids playing prom-
inent roles. Nutritional modulation of the microbiome can also be important, and there are
long-term, including inter-generational, effects of diet. The metabolic, molecular, and cellular
mechanisms that mediate both improvement in health during aging to diet and genetic variation
in the response to diet are being identified. These new findings are opening the way to specific di-
etary and pharmacological interventions to recapture the full potential benefits of dietary restriction,
which humans can find difficult to maintain voluntarily.Introduction
The discovery that aging can be ameliorated by dietary, genetic,
and pharmacological interventions has opened up the prospect
of a broad-spectrum, preventive medicine for aging-related
diseases (Table 1) (Fontana et al., 2014; Goldman et al., 2013;
Partridge, 2010). Single-gene mutations that extend animal life-
span can ameliorate natural, age-dependent loss of function
(Metaxakis et al., 2014; Stein and Murphy, 2012) and the pathol-
ogy of aging-related diseases, including neurodegeneration (Co-
hen et al., 2009; Killick et al., 2009; Menzies and Rubinsztein,
2010; Pinkston-Gosse and Kenyon, 2007; Sto¨hr et al., 2013).
Furthermore, laboratory animal models of slowed aging, natu-
rally long-lived species such as the naked mole rat, and some
humans that achieve the age of 100 have all demonstrated that
a long life is not inevitably associated with late-life disability
and disease (Ikeno et al., 2006; Edrey et al., 2011; Ailshire
et al., 2014). Recent work has shown that specific dietary inter-
ventions can also promote long life and healthy old age.
Dietary restriction (DR), implemented as chronic and coordi-
nate reduced intake of all dietary constituents except vitamins
and minerals, was first shown 80 years ago to extend lifespan
in rats. DR in both rats and mice improves most aspects of
health during aging (Fontana et al., 2010a; Ikeno et al., 2006;
Maeda et al., 1985). Exceptions include resistance to infection
and wound healing. However, these conditions rapidly
improve with re-feeding, and DR animals can then outperform
controls (Kristan, 2008; Hunt et al., 2012). DR can produce
substantial benefits with, for instance, 30% of DR animals
dying at old ages without gross pathological lesions,106 Cell 161, March 26, 2015 ª2015 Elsevier Inc.compared with only 6% of ad-libitum-fed controls (Ikeno
et al., 2006). DR started in young, adult Rhesus monkeys
greatly improves metabolic health; prevents obesity; delays
the onset of sarcopenia, presbycusis, and brain atrophy; and
reduces the risk of developing and dying of type 2 diabetes,
cancer, and cardiovascular disease (Colman et al., 2014; Mat-
tison et al., 2012).
In humans, severe food restriction without malnutrition results
in many of the same physiological, metabolic, and molecular
changes associated with DR in animals, including less age-asso-
ciated myocardial stiffness and autonomic dysfunction, lower
core body temperature, and downregulation of the pi3k/akt/
foxo and inflammatory pathways in skeletal muscle (Cava and
Fontana, 2013; Mercken et al., 2013). Furthermore, humans
voluntarily undertaking long-term DR score lower than controls
on multiple risk factors for cardiovascular disease and cancer
(Fontana et al., 2010b). In short-term, randomized clinical trials
in aging humans, DR improves several markers of health (Heil-
bronn et al., 2006; Fontana et al., 2010b). However, severe DR
with adequate nutrition (i.e., consuming at least 100% of the
RDI for each essential nutrient) is not an option for most people
because it is difficult to practice and sustain and, with inade-
quate nutrition, can increase the risk of impaired menstrual and
reproductive function, osteoporotic bone fractures, anemia,
and cardiac arrhythmias (Fairburn and Harrison, 2003). Dietary
interventions that avoid unrealistic levels of self-deprivation,
and pharmacological interventions that recapture beneficial ef-
fects of DR, are therefore important goals to improve human
health during aging.
Table 1. Interventions Extending Mean and/or Maximal Lifespan in Wild-Type Mice Fed Normal Chow
Max Lifespan Mean Lifespan Main Mechanism of Action
Dietary Interventions
Calorie restriction yes yes Y nutrient-sensing pathways
Intermittent fasting yes yes Y nutrient-sensing pathways
Protein restriction no yes Y nutrient-sensing pathways
Methionine restriction yes yes Y nutrient-sensing pathways
Tryptophan restriction yes yes Y nutrient -sensing pathways
Physical Exercise Interventions
Endurance exercise no yes [ insulin sensitivity; [ AMPK ?
Genetic Interventions
Ames and Snell dwarf yes yes Y nutrient-sensing pathways
GH receptor KO yes yes Y nutrient-sensing pathways
IGF-1 R KO yes (in F) yes (in F) Y nutrient-sensing pathways
Klotho TG yes (in M) yes Y nutrient-sensing pathways
Fat Insulin Receptor KO yes yes Y nutrient-sensing pathways
Insulin Receptor Substrate 1 KO yes (only F) yes (only F) Y nutrient-sensing pathways
Brain IRS-2 KO yes yes Y nutrient-sensing pathways
PAPP-A KO yes yes Y nutrient-sensing pathways
Ribosomal S6 protein kinase-1 KO yes (only F) yes (only F) Y nutrient-sensing pathways
FGF-21TG yes yes Y nutrient-sensing pathways
miR-17TG ? yes Y nutrient-sensing pathways
DGAT1KO yes (only F) yes (only F) Y nutrient-sensing pathways
p66shc KO yes yes Y growth factor-mediated signaling
ATG5 TG yes yes [ autophagy
Type 5 Adenylyl Cyclase KO yes yes Y b-adrenergic signaling
Angiotensin II type 1 receptor KO yes yes Y angiotensin receptor signaling
Catalase targeted to mitochondria TG yes yes Y oxidative stress (mitochondrial)
Ink4/Arf-TG/TG no yes Y mitogenic over-stimulation and cell proliferation
C/EBP b/b yes yes [ mitochondrial biogenesis in white fat cells
Mclk1KO yes yes Y age-dependent loss of mitochondrial function
Hcrt-UCP2 TG no yes ?; Y core body temperature
Macrophage migration inhibitory factor KO yes yes Y inflammation; Y insulin pathway
E-DNIkB TG ? yes Y inflammation; Y insulin pathway
PKA RIIb KO yes yes Y IGF signaling?
RasGRF1 KO yes yes Y nutrient-sensing pathways
Sirt6 TG yes (only M) yes (only M) Y nutrient-sensing pathways (IGF)
Brain-specific Sirt1 TG yes (only F) yes [ mitochondrial function via Sirt1/Nkx2-1/Ox2r
TRPV1 pain receptor KO yes (only F) yes modulation of CRTC1/CREB activity
Pharmacological Interventions
Rapamycin yes yes Y nutrient-sensing pathways (mTOR)
Acarbose yes yes Y IGF signaling and [ FGF-21
Metformin no yes Y nutrient-sensing pathways (AMPK)
Aspirin no yes (only M) Y inflammation
Nordihydroguaiaretic acid no yes (only M) Y inflammation and oxidative stress
Green tea extract no yes (only F) Y oxidative stress
17a-Estradiol (non-feminizing estrogen) no yes (only M) ? non-genomic actions
Methylene Blue no yes (only F) [ mitochondrial function
Metoprolol no yes (in M) Y b-adrenergic receptor signaling
Nebivolol no yes (in M) Y b-adrenergic receptor signalingDR increases healthy lifespan in many shorter-lived organ-
isms, including budding yeast Saccharomyces cerevisiae, the
nematode worm Caenorhabditis elegans, and the fruit fly
Drosophila melanogaster (Figure 1). The experimental tractabilityof yeast and invertebrates facilitates discovery of the—often
evolutionarily conserved—mechanisms through which genetic
and environmental intervention improve health during aging.
Themechanismsmediating the health benefits of DR are not fullyCell 161, March 26, 2015 ª2015 Elsevier Inc. 107
Figure 1. Dietary Restriction Increases Healthy Lifespan in Diverse
Single-Celled, Invertebrate, and Vertebrate Animalsunderstood in any organism. A wide range of interventions has
been used to impose DR, even within single species, and the
mechanisms through which they extend lifespan can differ
(Bass et al., 2007; Cypser et al., 2013; Mair and Dillin, 2008; Tatar
et al., 2014). Multiple neural, systemic, tissue-specific, and cell-
autonomous mechanisms are involved (Figure 2). In both
C. elegans and Drosophila, altered sensory perception alone
may play a role, with specific subsets of sensory, including olfac-
tory and gustatory, neurons influencing lifespan (Alcedo and
Kenyon, 2004; Allen et al., 2014; Apfeld and Kenyon, 1999;
Ostojic et al., 2014; Waterson et al., 2014). In C. elegans,
Drosophila, and mice, neural circuits both detect nutrient status
and control the responses to it, in mice mediated mainly by the
hypothalamus (Dacks et al., 2013). Alterations in the following
also play important systemic roles: the levels of metabolites
(Chin et al., 2014), the activity of the nutrient-sensing insulin/igf
signaling network (Johnson et al., 2013; Kenyon, 2010) in
C. elegans, steroid hormone signaling (Thondamal et al., 2014),
and growth hormone in themouse (Johnson et al., 2013; Kenyon,
2010). Cellular effector processes can include enhanced
genomic stability and chromatin remodeling (Dang et al.,
2014); improved chaperone-mediated protein homeostasis and
cellular turnover processes, including autophagy (Singh and
Cuervo, 2011); and increases in various forms of stress resis-
tance (Hine et al., 2015). Molecular effectors that have been
shown to mediate the effects of DR on health and longevity
include FOXO (Tullet et al., 2008; Webb and Brunet, 2014),
TOR (Kapahi et al., 2010; Johnson et al., 2013), AMPK (Greer
et al., 2007; Burkewitz et al., 2014), sirtuins (Mouchiroud et al.,
2013; Guarente, 2013), HSF, and NRF2 (Akerfelt et al., 2010;
Martı´n-Montalvo et al., 2011). Inhibition of AKT activates
FOXO, a transcription factor that upregulates several ‘‘longevity
pathways’’ controlling DNA repair, autophagy, antioxidant activ-
ity, stress resistance, and cell proliferation (Webb and Brunet,
2014;Wang et al., 2014). Inhibition of mTORC1 improves proteo-
stasis, increases autophagy, and enhances stem cell function
(Kapahi et al., 2010; Efeyan et al., 2012; Johnson et al., 2013).
Systemic or tissue-specific overexpression of some sirtuins
(i.e., SIRT1, SIRT3, and SIRT6) also increases genomic stability,
reduces NF-kB signaling, and improves metabolic homeostasis
through histone deacetylation (Mouchiroud et al., 2013; Guar-
ente, 2013). Moreover, activation of SIRT1 and AMPK activates108 Cell 161, March 26, 2015 ª2015 Elsevier Inc.PGC-1a, a transcriptional regulator of mitochondrial function,
antioxidant defenses, and fatty acid oxidation (Wu et al., 1999).
Activation of transcription factors heat shock factor 1 and Nrf2,
by upregulating HSP70, p62, and the transcription factor ATF3,
induces several antioxidant and drug-metabolizing enzymes,
prevents the age-dependent impairment of proteostasis, and
promotes the maintenance of cell structure, redox, and interme-
diary metabolism (Akerfelt et al., 2010; Martı´n-Montalvo et al.,
2011). Multiple, parallel processes thus contribute to the in-
crease in health during aging from DR, and the relative contribu-
tion of these may vary between DR regimes and organisms.
Interestingly, recent work has revealed the importance of
timing of food intake, the role of specific nutrients, the nature
of the effector mechanisms, the longer-term—including trans-
generational—consequences of diet, and the key role played
by the gut microbiota (Figure 3). These new findings have
pointed to less drastic dietary manipulations that could be com-
bined with pharmacological interventions to improve health and
prevent disease during aging.
Meal Frequency and Timing
Only recently have humans and domesticated animals had con-
stant access to food. During their evolution, many animals and
humans ate only intermittently. For many microorganisms and
invertebrates, long periods of starvation are normal and, corre-
spondingly, many of them (including C. elegans) have evolved
forms of quiescence in response to the onset of food shortage.
Many of the genes that control quiescence are also important
in the control of lifespan (Baugh, 2013). Interestingly, intermittent
fasting (IF), with alternation of 2 days of ad libitum feeding with
2 day fasting, also extends worm lifespan, through a mechanism
involving the small GTP-ase RHEB-1 and insulin/Igf signaling
(Honjoh et al., 2009). Even chronic starvation extends lifespan
in C. elegans (Kaeberlein et al., 2006; Lee et al., 2006), through
mechanisms that overlap with those mediating the response to
IF and that include the combined activity of FOXO, FOXA, and
AP-1 transcription factors in two parallel starvation-responsive
pathways (Uno et al., 2013).
In rodents, both fasting for 24 hr every other day or twice
weekly extends lifespan up to 30%, independent of both total
food intake and weight loss (Mattson et al., 2014). As for chronic
DR, the magnitude of the life extension induced by IF can be
influenced by the age of initiation and mouse genotype. In A/J
mice, for example, IF started at 6 months did not increase life-
span and, when started at 10 months of age, reduced mean life-
span by 15% (Goodrick et al., 1990), although it is not clear
whether a more or less severe form of IF could extend lifespan
in thesemice. IF can also protect against obesity, cardiovascular
disease, hypertension, diabetes, neurodegeneration, and the
clinical progression of several neurodegenerative diseases
(Mattson et al., 2014). In contrast, although many studies report
a protective effect against cancer progression (Berrigan et al.,
2002; Lee et al., 2012), others suggest detrimental cancer initia-
tion and promotion (Tessitore and Bollito, 2006). In rodents, mul-
tiple changes mediate benefits of fasting, including increased
production of the neurotrophic factors BDNF and FGF2, reduced
inflammation and oxidative stress, and enhanced cellular and
molecular adaptive stress responses. Treatment of cells and
Figure 2. Dietary Restriction Modulates Mul-
tiple Systemic, Neural, and Cellular Mecha-
nisms that Improve Health and Combat the
Diseases of Agingmice with bOHB, an endogenous histone deacetylase inhibitor
powerfully induced by fasting, protects against oxidative stress
(Shimazu et al., 2013). Fasting improves mitochondrial function,
stimulates the production of chaperones such as HSP-70 and
GRP-78, and, by inhibiting the AKT/mTOR pathway, triggers
autophagy and DNA repair pathways in multiple cell types
(Brown-Borg and Rakoczy, 2013; Mattson et al., 2014). More-
over, in mice, multiple cycles of fasting modulate hematopoietic
stem cell protection, self-renewal, and regeneration via IGF-1
or PKA inhibition (Cheng et al., 2014). Finally, short-term fasting
(1–3 days) has been shown to protect rodents against the dam-
age induced by ischemia-reperfusion of the liver and kidney, by
improving insulin sensitivity, reducing expression of markers of
inflammation and insulin/igf-1 signaling, and increasing cytopro-
tective gene expression (Hine et al., 2015).
Many trials on the effects of IF in humans are underway. A
6 month, randomized, clinical trial in overweight or obese pre-
menopausal women showed that fasting for 2 non-consecutive
days per week results in reduced body weight, fat mass, and
waist circumference and also reduced serum concentrations of
total and LDL cholesterol, triglycerides, C-reactive protein, and
arterial blood pressure. Several serum biomarkers of cancer
risk also improved, but total and free IGF-1 did not change (Har-
vie et al., 2011). Similarly, in three small, short-term (8–12weeks),
randomized clinical trials in non-obese and obese individuals,
alternate day fasting lowered bodyweight, fatmass, and risk fac-
tors for cardiovascular disease (Kroeger et al., 2014). Preliminary
evidence from dogs and humans suggests that short-term fast-
ing (24–48 hr) prior to chemotherapy reduces some chemo-
therapy-associated side effects by protecting normal cells, but
not cancer cells, from toxicity (Safdie et al., 2009; Withers
et al., 2014).
Patterns of eating over the day can also have substantial ef-
fects. Limiting daily food intake of an isocaloric diet to a 5 to
7 hr time window in humans can induce health benefits
compared with a standard three to five meals per day (Mattson
et al., 2014). Delaying feeding until the evening in diurnally active
fruit flies, which normally eat predominantly in the morning,Cell 1causes an uncoupling of their metabolic
cycle from the central circadian rhythm
and reduces egg laying (Gill and Panda,
2011). Time-restricted feeding of mice
during 8 hr of the dark phase of the daily
cycle does not affect overall calorie intake
of mice on a high-fat diet but restores
normal circadian rhythms of activity in
metabolic pathways and protects the
mice against weight gain, fat accumula-
tion, inflammation, glucose intolerance, in-
sulin resistance, and loss of endurance
and motor coordination (Chaix et al.,2014). Humans who eat and sleep12 hr out of phase from their
habitual patterns experience increased blood pressure, wors-
ening of glucose tolerance, a reduction of the satiety hormone
leptin, and a complete inverse pattern of the cortisol rhythm
(Scheer et al., 2009). Although randomized clinical studies on ef-
fects of chronic disruption of meal patterns and circadian
rhythms, as in shift workers, have yet to be performed, epidemi-
ological data suggest an increased risk of obesity, type 2 dia-
betes, cardiovascular disease, cancer, and neurodegenerative
diseases (Wang et al., 2011). Furthermore, 30% calorie restric-
tion by dietary dilution, in which mice ate all day to compensate
for the low energy density of the diet, had no beneficial effects on
lifespan (Solon-Biet et al., 2014), possibly because of the disrup-
ted meal pattern. Long-lived, hungry DR mice and rats consume
their restricted portion of food rapidly, with an extended period of
fasting (22–23 hr) between meals. Chronic DR may hence
improve health at least in part through IF. Similarly, in the Wis-
consin Rhesus monkey DR trial, the animals fed mainly once a
day—in the National Institute on Aging (NIA) trial twice daily
(Table 2)—which may have contributed to the Wisconsin DR
monkeys having a 1.83 lowered rate of death from any cause
(Colman et al., 2014) in contrast with the absence of a difference
in death rate in the NIA study (Mattison et al., 2012) (reviewed in
Cava and Fontana, 2013). Interestingly, both in overweight/
obese and lean women with polycystic ovary syndrome, sub-
jects randomized to earlier meal timing (980 kcal breakfast,
640 kcal lunch, and 190 kcal dinner) lost more weight, displayed
higher insulin sensitivity, lower serum testosterone concentra-
tion, and increased ovulation rate than controls eating isocaloric
diets with a latermeal pattern (190 kcal breakfast, 640 kcal lunch,
and 980 kcal dinner) (Jakubowicz et al., 2013).
The molecular mechanisms responsible for the effects of
altered meal patterns on metabolic health are not fully under-
stood. There may be compensatory changes in energy sensing
pathways, such as AMPK, AKT/mTOR, and cyclic AMP
response element binding protein (CREB), which are all impli-
cated in cellular homeostasis and rhythmic oscillations of circa-
dian clock targets (Mattson et al., 2014). Transgenic mice61, March 26, 2015 ª2015 Elsevier Inc. 109
Figure 3. The Effectors of Dietary Restriction, Including Timing of
Food Intake, Specific Nutrients—Especially Proteins and Particular
Amino Acids—the Gut Microbiome, and Longer-Term Mechanisms,
Including Developmental Programming and Trans-generational
Effects, Modulate Key Mechanisms Associated with Healthy Agingcarrying a S714G mutation in hPER1, a circadian clock gene,
quickly develop obesity on a high-fat diet (Liu et al., 2014). An
isocaloric reduction of fat intake only during the night is sufficient
to prevent obesity in these animals (Hatori et al., 2012), suggest-
ing that altered meal pattern alone could be used to prevent
certain metabolic diseases (Garaulet et al., 2013; Jakubowicz
et al., 2013). Interestingly, a diet high in fat induces a rapid and
reversible impairment of BMAL1 recruitment to target chromatin
sites and modifies circadian transcriptome and metabolome
profiles (Eckel-Mahan et al., 2013). The profound effects of
timing of food intake have hence opened a promising avenue
for interventions to improve humans’ health during aging.
Calories or Specific Nutrients?
Determining the optimal overall intake and dietary ratios of car-
bohydrate, fat, and protein is challenging. The effects of reduced
consumption of a specific macronutrient will depend partly upon
how much of it is consumed by the controls and also upon the
composition of the rest of the diet. Even for just three macronu-
trients, the possible combinations are vast. Combinatorial ef-
fects can be explored using a geometric framework (see the
Essay by Simpson et al. (2015) on page 18 of this issue), but
this is often not feasible in practice. Dietary composition can
also affect overall food intake and its timing through effects on
hedonistic value and satiety. Although such mechanisms are
important to understand, they can also complicate analysis of
the effects of nutrient intake per se. The effects of diet on health
may also be age specific, a possibility that is starting to be
explored experimentally in humans (Wolfe et al., 2008).110 Cell 161, March 26, 2015 ª2015 Elsevier Inc.Macronutrients
Until recently, reduced intake of calories, rather than of specific
macronutrients, was considered important for health benefits of
DR. This assumption was primarily based on a flawed interpreta-
tion of experimental data showing that 40% calorie restriction,
but not 40%protein restriction, increased lifespan in rats (Maeda
et al., 1985). However, the protein-restricted rats were not food
restricted, because their growth rate was normal, a point over-
looked by the authors of the study. A subsequent series of
studies in yeast, invertebrate model organisms and rodents
has instead clearly demonstrated that a reduction in specific nu-
trients in the diet, rather than reduced calorie intake, is primarily
responsible for improvements in health and extended lifespan,
which is why we use the term DR rather than CR.
Protein and Amino Acids
Dietary guidelines from the medical literature and popular press
often promulgate high protein intake, especially from animal
sources rich in essential amino acids, including sulfur-containing
and branched chain, to combat obesity, sarcopenia, osteopo-
rosis, frailty, surgical stress, and mortality. However, accumu-
lating evidence points instead to a restriction of protein or
specific amino acids in the diet as promoting healthspan (Gran-
dison et al., 2009; Solon-Biet et al., 2014; Ables et al., 2014; Na-
kagawa et al., 2012; Pamplona and Barja, 2006; Mirzaei et al.,
2014). This conclusion initially emerged from investigation of
the nutrients mediating the effects of DR and has since been
amplified in broader studies of the effects of dietary composition
and intake on health and lifespan.
In Drosophila, restriction of protein-containing yeast, but not
carbohydrate or energy, extends lifespan (Mair et al., 2005). Add-
ing back essential amino acids to the diet of DR flies decreases
lifespan, with the addition of non-essential amino acids, lipid, or
carbohydrate exerting little or no effect (Grandison et al., 2009).
In mice, also, health and lifespan are strongly affected by the
protein component of the diet, with median lifespan progres-
sively increasing up to 30% as the dietary protein-to-carbohy-
drate ratio is decreased, despite a parallel increase in overall
food intake and body fat and reduction in lean mass (Solon-
Biet et al., 2014).
Dietary protein intake is an important regulator of the IGF-1/
mTOR network (Efeyan et al., 2012). In humans, unlike rodents,
chronic severe calorie restriction does not reduce serum IGF-1
concentration unless protein intake is also reduced (Fontana
et al., 2008), suggesting that dietary protein or specific amino
acid intake may be as or more important than calorie intake in
modulating IGF-related biological processes and disease risk
in men and women. In rodents, over-stimulation of the GH/IGF
pathway accelerates aging and increases mortality, whereas
downregulation slows aging, prevents cancer, and increases
lifespan (Junnila et al., 2013). Moreover, serum IGF-1 concentra-
tion is inversely correlated with median lifespan in 31 genetically
diverse, inbredmouse strains (Yuan et al., 2009) and with the risk
of developing some common cancers in humans (Pollak, 2012).
Interestingly, isocaloric restriction of protein and substitution of
plant for animal proteins markedly inhibit prostate and breast
cancer growth in human xenograft animal models of neoplasia,
with reduced serum IGF-1 levels and downregulation of intratu-
mor mTOR activity, histone methyltransferase EZH2, and the
Table 2. Characteristics of the University of Wisconsin and NIA DR Monkey Studies
University of Wisconsin National Institute on Aging
Rhesus monkeys (n) 76 (46 m, 30 f) 120 (60 m, 60 f)
Genetic origin of monkeys India China and India
Age at baseline all adult juvenile (20 m, 20 f); adolescent (20 m, 20 f);
old (20 m, 20 f)
Housing single caged single caged
Randomization 1 CR: 1 control 1 CR: 1 control
Dietary regimen of CR monkeys 30% restriction from a BL intake assessed
individually
30% restriction from BL intake levels based
on NRC guidelines
Dietary regimen of control monkeys fed ad libitum controlled allotment of food each day to avoid
obesity (5%–10% CR)
Meal patterns morning meal, plus 100 Kcal integration of food
at late afternoon
twice a day
Source of nutrients semi-purified diet rich in refined foods natural ingredients (pesco-vegetarian diet)
Macronutrient composition of diets 15% protein (lactalbumin); 10% fat (corn oil); 65%
carb (cornstarch, sucrose); 28.5% from sucrose;
5% fiber
17.3% protein (fish, soybean, wheat, corn);
5% fat (fish, soy oil, wheat, corn, alfalfa);
56.9% carb (ground wheat and corn); 3.9%
from sucrose; 5%–7% crude fiber
Vitamin supplements only for CR monkeys 40% of RDA in vitamin in both control and CR
monkeys
Food intake measurement daily quantification for each animal 1 week per yearassociated histone mark H3K27me3, two epigenetic markers of
prostate cancer progression (Fontana et al., 2013).
Within the protein component of the diet, specific amino acids
or their ratio can be important for health and lifespan. Selective
restriction of asparagine, glutamate, or methionine in the me-
dium has been shown to extend chronological lifespan in yeast
(Dilova et al., 2007; Wu et al., 2013a, 2013b). In Drosophila and
rodents, restriction of methionine and tryptophan, respectively,
extends average and maximal lifespan (Ables et al., 2014; Miller
et al., 2005; Zimmerman et al., 2003). In the DR Rhesus monkey
trials, the Wisconsin diet contained higher concentrations of
methionine and branched-chain amino acids derived from lactal-
bumin than did the NIA diet (Table 2), which could explain some
of the differences in effects on cancer and mortality.
Amino acid availability is sensed bymultiple evolutionarily con-
servedmolecular pathways, themost important beingmTOR and
GCN2. Activation of mTOR is modulated by different essential
amino acids in a tissue-specific manner, with branched-chain
amino acids playing a key role (Efeyan et al., 2012). In contrast,
absence of any individual amino acid activates GCN2, which is
required for the protective effect of short-term protein or trypto-
phan deprivation on surgical stress in mice (Peng et al., 2012).
The protein/amino acid restriction-induced protective mecha-
nisms against stress, damage accumulation, and aging down-
stream of TOR inhibition and GCN2 activation are unknown.
Nonetheless, GCN2 activation stabilizes ATF4, a transcription
factor essential for the Integrated Stress Response, which is
elevated in several dietary, genetic, and pharmacological animal
models of longevity (Li et al., 2014; Hine et al., 2015).
Reduced dietary methionine, in particular, induces specific,
protective, molecular mechanisms. The sulfur-containing amino
acids methionine and cysteine are metabolized through thetrans-sulfuration pathway, lesions in which are associated with
increased incidence of age-related pathologies in humans. DR
in Drosophila results in increased activity of the rate-limiting
enzyme in the trans-sulfuration pathway, and inhibition of the
pathway blocks the response of fly lifespan to DR. Furthermore,
transgene-mediated increase in activity of the pathway in-
creases fly lifespan (Kabil et al., 2011). Interestingly, the trans-
sulfuration pathway is the primary source of hydrogen sulfide in
cells, and hydrogen sulfide can increase lifespan in C. elegans
(Miller and Roth, 2007). Furthermore, a trans-sulfuration-
pathway-dependent increase in production of hydrogen sulfide
is seen in yeast, worm, fruit fly, and rodent models of DR, and
in mice DR-induced resistance against ischemia reperfusion
injury requires this increase (Hine et al., 2015). Interestingly, in
the long-lived Ames dwarf mouse, which lacks growth hormone,
expression of genes in the trans-sulfuration pathway and the flux
of methionine to the pathway are increased, associated with
higher levels of GSH (Uthus and Brown-Borg, 2006). The lifespan
of Ames dwarf mice and of mice lacking the growth hormone re-
ceptor is extended relative to controls on normal diet but does
not respond to methionine restriction and then becomes similar
to that of controls (Brown-Borg et al., 2014). Thus, the increased
health during aging of these somatotropicmutantmicemay be at
least in part attributable to increased trans-sulfuration activity.
In humans, little is known on the effects of dietary modifica-
tions of protein quantity and quality in modulating molecular
pathways that control aging, stress resistance, and age-associ-
ated diseases. Nonetheless, ongoing clinical trials should soon
begin to reveal themetabolic andmolecular adaptations induced
by protein restriction and alterations of amino acid intake in
relativity healthy overweight human subjects and in cancer
patients.Cell 161, March 26, 2015 ª2015 Elsevier Inc. 111
Microbiota-Derived Factors and Healthy Aging
In humans, only10%of cells and less than 1%of genes are hu-
man, and the rest come from trillions of microbes in the gastro-
intestinal tract. Rapidly accumulating metagenomic data indi-
cate that altered food intake, especially protein and insoluble
fiber, have rapid and profound effects on gut microbiota struc-
ture, function, and secretion of factors that modulate multiple
inflammatory and metabolic pathways (Muegge et al., 2011;
Clemente et al., 2012; David et al., 2014; Thorburn et al.,
2014). G-protein-coupled receptors expressed by enteroendo-
crine and immune cells may be important mediators of the ef-
fects of the microbiome (Thorburn et al., 2014). For example,
oral administration to mice of 17 non-pathogenic Clostridia spe-
cies isolated from healthy human fecal samples results in gut mi-
crobiota that provide short-chain fatty acids, bacterial antigens,
and a TGF-b-rich environment, which help differentiation, expan-
sion, and colonic homing of Treg cells and reduce disease
severity in multiple models of colitis and allergic diarrhea (Atara-
shi et al., 2013). In contrast, diet-induced microbiota dysbiosis is
associated with increased risk of developing cardiovascular dis-
ease, obesity-associated metabolic abnormalities, cancer, and
autoimmune and allergic disease (Clemente et al., 2012).
In nature, C. elegans feeds on a variety of bacterial species
that grow on rotting vegetation, which also constitute the gut mi-
crobiome of the worm. Feeding C. elegans with soil bacteria,
Bacillus mycoides, and Bacillus soli instead of the standard lab-
oratory E. coli OP50 strain, significantly extended lifespan and
stress resistance, suggesting that microbial-derived factors
may modulate pro-longevity pathways (Abada et al., 2009).
Moreover, wild-type C. elegans fed respiratory-incompetent
E. coli show increased lifespan (Saiki et al., 2008). A comparison
of the effects of E. coli and Comamonas aquatica on the
C. elegans host identified vitamin B12 as a major diffusable
factor from Comamonas that influenced patterns of gene
expression and the rate of development and fertility of the
worm (Watson et al., 2014). Interestingly, effects of chemicals
on the worm can also be mediated by the gut microbiome. Met-
formin, the drug used as the first line of defense against type 2
diabetes, extends lifespan ofC. elegans fed on live, but not killed,
E. coli, and it does so by disrupting the folate cycle and methio-
nine metabolism of the E. coli. In consequence, the supply of
bacterial methionine to the worm is reduced, inducing a type of
methionine restriction, which is consistent with the action ofmet-
formin as a DRmimetic (Cabreiro et al., 2013). The relatively sim-
ple gut microbiome of Drosophila is also derived from its food
intake, and bacterial density and composition have a substantial
effect upon the fly host (reviewed in Erkosar and Leulier, 2014).
Bacterial density increases during the aging of the fly and can
compromise gut integrity (Guo et al., 2014). The normal comple-
ment of gut bacteria enables the flies to use low-nutrient or un-
balanced diets by providing them with B vitamins, particularly
riboflavin, and by promoting protein nutrition (Wong et al., 2014).
Alterations in the gut microbiome may contribute to the
improvement in health from DR and time-restricted feeding.
Long-term dietary restriction of mice, with either a normal or a
high-fat diet, leads to alterations in composition of the gut micro-
biome, although any contribution of these changes to the health
of the DR mice remains to be elucidated (Zhang et al., 2013). In112 Cell 161, March 26, 2015 ª2015 Elsevier Inc.mice on a high-fat diet, time-restricted feeding during 8 hr of the
dark phase decreased representation of Lactobacillus species,
which are associated with obesity, and increasedRuminococca-
ceae species, which protect against metabolic disease associ-
ated with obesity (Zarrinpar et al., 2014). Experimental transplan-
tations of microbiota associated with healthy eating could be
revealing of their causal role.
Health, Disease, and Longevity on Various Timescales,
Including Inter-generational
The effects of nutrition, including DR, can be exerted on time-
scales ranging from more or less instantaneous to inter-genera-
tional. For instance, in Drosophila, DR acts acutely, with flies
switched between DR and ad libitum feeding almost immediately
adopting the mortality pattern of a control group kept perma-
nently in the feeding regime that the switched flies join (Mair
et al., 2003). At least as reflected in their mortality rate, these flies
thus have no memory of their nutritional history, and their pat-
terns of gene expression also change rapidly in response to
DR (Whitaker et al., 2014). In contrast, the mortality rates of
C. elegans subjected to one form of DR retain a permanent mem-
ory of the previous feeding regime after a dietary switch (Wu
et al., 2009). The mortality rates of mice and rats subjected to
switches between DR and AL feeding later in life have shown
mixed responses, but a meta-analysis suggests that there is a
permanent memory of diet in these animals (Simons et al.,
2013). Similarly, even short episodes of DR early in adulthood
in male mice can induce a glycemic memory apparent as
increased glucose tolerance (Cameron et al., 2012; Selman
and Hempenstall, 2012). However, in mice and humans, acute
responses to DR also occur, including improved insulin sensi-
tivity, reduced inflammation, and protection against ischemia re-
perfusion injury and other surgical stressors (Hine et al., 2015).
Developmental Programming
In contrast to immediate effects of diet, in mammals (including
humans), nutrition in early life (including in utero) can have lasting
effects on health during aging, often referred to as developmental
programming. For instance, undernourished rat and mouse
mothers produce offspring with low birth weight and multiple
metabolic defects, including early-life adiposity, altered pancre-
atic function, and progressive glucose intolerance (Tarry-Adkins
and Ozanne, 2014; Vickers, 2014). Maternal effects on offspring
can include changes to the composition of the egg, alterations
to the environment in utero, and peri-natal effects such as
transmission of the microbiome and alterations to lactation, and
can be manifest in the offspring as changes in gene expression
and epigenetic modifications, including DNA methylation, his-
tone modification, and expression of microRNAs, as well as
evidence of increased cellular aging (Aiken and Ozanne, 2014;
Colaneri et al., 2013; Radford et al., 2012). Epidemiological
data from humans also show a consistent effect of develop-
mental programming by early—including in utero—nutrition,
although the evidence on themechanisms involved is necessarily
correlational rather than experimental. The thrifty phenotype
hypothesis (Hales and Barker, 2001) postulates that many of
the changes in organ structure and metabolism seen in humans
in response to restricted nutrition—particularly of protein—in
utero can be understood as the consequences of immediate
responses of the fetus to ensure survival and spare vital organs
such as the brain. Viewed in this way, an under-nourished fetus
makes the best of a bad job with adverse consequences for
health in later life, including reduced glucose tolerance and a
higher incidence of ischemic heart disease, problems that are
greatly exacerbated by subsequent adequate or over-nutrition.
However, a poor functional capacity for insulin secretion would
notbedetrimental to individualswhocontinued tobepoorly nour-
ished and remained thin and, therefore, insulin sensitive, and it
remains possible that some fetal and post-natal responses to
low nutrition are advantageous in conditions of continuing poor
nutrition.
Inter-generational Effects of Diet
Current nutrition may act as a predictor of future nutritional
conditions if food availability shows local variation or if timing
of natural cycles of food scarcity and abundance occurs on an
appropriate timescale. Under these circumstances, information
gained early in life or even in earlier generations could be profit-
ably used to anticipate future nutritional prospects and adjust
physiology accordingly (Rando, 2012). Such considerations
may partly explain why inter-generational effects of diet can
also be transmitted through males. The evidence for a role of
epigenetic inheritance in these cases is largely correlational,
and a direct experimental testing of the hypothesis is challenging
(Heard and Martienssen, 2014; Rando, 2012). Cellular mecha-
nisms by which metabolic changes can be communicated to
chromatin are being increasingly discussed (Gut and Verdin,
2013; Katada et al., 2012; Lu and Thompson, 2012).
InDrosophila, the sugar content of the paternal diet, even over
a 2 day period during which the offspring are sired, can elicit
increased lipid content in offspring. Sugar in the diet de-silences
chromatin-state-defined domains both in mature sperm and in
offspring embryos, and H3K9/K27me3-dependent reprogram-
ming of metabolic genes in two time windows in the germline
and the zygote is required for increased lipid content of offspring.
Furthermore, data from mice and humans, including discordant
humanmonozygotic twins, show a similar signature of chromatin
de-repression associated with obesity (O¨st et al., 2014).
Livers of offspring of male mice fed a low-protein diet show
elevated expression of genes involved in lipid and cholesterol
biosynthesis. These alterations are accompanied by subtle (in
the region of 20%) changes in DNA cytosine methylation in spe-
cific gene regions, including a putative enhancer for the lipid
regulator Ppara (Carone et al., 2010). Mice subjected to in utero
undernourishment are glucose intolerant, and they can transmit
the glucose intolerance even though they themselves are not un-
dernourished. They experience the effects of maternal under-
nourishment during a period that includes the time when their
germ cell DNA reacquires methylation. The sperm DNA of these
males is hypomethylated at multiple sites, especially ones en-
riched in regulatory elements and regulators of chromatin.
Although these altered methylation patterns are not apparent
in the tissues of their offspring, there are perturbations to gene
expression, possibly attributable to other types of epigenetic
alteration (Radford et al., 2014).
Evidence is also starting to point to truly inter-generational ef-
fects of diet, where information about dietary history is epigenet-
ically transmitted in the germline in the absence of any furtherinput from the organism or its environment. For instance, in the
nematode worm Caenorhabditis elegans, starvation-induced
developmental arrest has effects that persist for at least three
generations, with the third generation offspring of the starved
great-grandparents showing increased adult lifespan. The star-
vation event leads to the generation of small RNAs that are
also inherited for at least three generations, that target the
mRNAs of genes involved in nutrient reservoir activity (Rechavi
et al., 2014), and that are possibly also causal in the increased
lifespan of the third generation descendants. It is at present
not clear whether these more persistent effects of diet represent
non-adaptive perturbations to physiology, anticipatory program-
ming of an adaptive response to nutritional circumstances, or
both. Effects of nutrition of the paternal grandfather on grandchil-
dren have been reported in humans, but the mechanisms
responsible are unknown (Pembrey et al., 2014). Recent work
with mice has suggested that sex-of-parent-of-origin effects
may bemuchmore pervasive and influential than previously sup-
posed. Even though the number of imprinted genes in the
mammalian genome is predicted to be small, non-imprinted
genes can regulate the tissue-specific expression of many other
genes differently when transmitted by females or males, possibly
by physical interaction with imprinted loci (Mott et al., 2014).
These findings could have profound implications for human ag-
ing and disease.
Genetic Variation in Response to Diet
Individuals of different genotypes can respond differently to diet.
Although little studied outside the context of inborn errors of
metabolism, such genetic effects in humans are potentially
important for identifying sub-groups that would benefit from
dietary modulation. Females and males often respond very
differently to dietary and pharmacological interventions, and ev-
idence is mounting for the importance of other types of genetic
variation.
DR has proved to extend lifespan in most species examined,
including many non-model organisms, although it has been sug-
gested that increased lifespan in response to DR may have
evolved in part as an artifact of laboratory culture (Nakagawa
et al., 2012). However, strains of C. elegans and Drosophila
collected directly from nature respond normally to DR (Metaxa-
kis et al., 2014). Wild-derived mice, on the other hand, can
show little or no response (Harper et al., 2006). The stresses of
captivity in non-domesticated animals could be part of the expla-
nation for this finding. In addition, wild mice may respond to
milder or stronger DR than the single level used in the investiga-
tion (Gems et al., 2002). A similar experimental approach applied
to recombinant inbredmouse strains, using a single, 40% reduc-
tion in overall intake showed a range of responses from a 98%
extension of lifespan to a 68% reduction (Liao et al., 2010). A
wider range of reductions intake would have revealed whether
these strains differ only in the intake level at which their lifespan
peaks under DR or whether DR indeed does not extend lifespan
in some strains. In general, the lifespans of model organisms
show a tent-shaped response to the level of food intake, with
peak lifespan at intermediate food intake and a decline through
starvation to the left and through increased levels of food intake
to the right (Partridge et al., 2005). In order to determine whetherCell 161, March 26, 2015 ª2015 Elsevier Inc. 113
a strain or species responds to DR, a range of degrees of food
intake should therefore be explored (Gems et al., 2002). The
apparent lack of response of lifespan to DR trials in the NIA rhe-
susmonkey trial may have been at least in part attributable to the
5%–10% DR applied to the control animals, which may have
been sufficient to bring them close to peak lifespan.
Experimental analysis of genetic effects on the response to DR
has tended to focus on major genetic variation, caused by either
specific gene mutants or inbreeding (Schleit et al., 2013).
Although this approach can be informative about mechanisms
of the normal response to DR and hence candidates for disease
prevention in humans, it may not reveal much about the effects of
natural genetic variation in outbred human populations. It is
becoming clear that such variation is important. For instance, in-
terventions to reduce weight often have beneficial effects on
blood lipid profiles, type 2 diabetes, and risk of cardiovascular
disease, but some individuals respond poorly or not at all, thus
limiting the effectiveness and increasing the cost of intervention
programs. A study of the effects on blood lipid profiles and dia-
betes of increased exercise and lowered intake of fat revealed
that a higher genetic risk score for dyslipidemia based upon
SNP genotyping was associated with a substantially diminished
response to intervention (Pollin et al., 2012). Studies of this kind
could also throw light on underlying mechanisms and, hence,
individually targeted dietary and other types of intervention that
could be effective in preventing disease.Conclusions and Future Perspectives
Recent and accumulating work in unicellular and invertebrate
model organisms, rodents, monkeys, and humans indicates
that diet has a much more pervasive and prominent role than
previously thought in modulating mechanisms of aging and its
associated diseases. More work is needed to understand the in-
teractions among calorie intake, meal frequency and timing, sin-
gle-nutrient modifications, the microbiome, and nutritional his-
tory in modulating the key mechanisms that maintain cellular,
tissue, and organ function during aging. Development of bio-
markers is also urgently needed to delineate the differences
between an optimal dietary regime and starvation, taking into ac-
count individual variation in genotype and epigenotype. Finally,
we need to discover predictive biomarkers that can be used in
design of randomized clinical trials to test the efficacy of selected
dietary and/or pharmacological interventions on risk of disease,
including cancer, cognitive impairment, metabolic disease,
frailty, and the rate of biological aging.ACKNOWLEDGMENTS
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